Shopping Cart 0
Cart Subtotal
USD 0

Cognitive Disorders Global Clinical Trials Review, H2, 2019

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
USD 2500

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Site License
USD 5000

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
USD 7500

Details

Cognitive Disorders Global Clinical Trials Review, H2, 2019

Summary

GlobalData's clinical trial report, Cognitive Disorders Global Clinical Trials Review, H2, 2019" provides an overview of Cognitive Disorders clinical trials scenario. This report provides top line data relating to the clinical trials on Cognitive Disorders. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database-Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides a snapshot of the global clinical trials landscape

- Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status

- The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company

- The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment

- The Report provides enrollment trends for the past five years

- Report provides latest news for the past three months

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to buy

- Assists in formulating key business strategies with regards to investment

- Helps in identifying prominent locations for conducting clinical trials which saves time and cost

- Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities

- Supports understanding of trials count and enrollment trends by country in global therapeutics market

- Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials

- Facilitates clinical trial assessment of the indication on a global, regional and country level

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

READ MORE

Table Of Content

Scope

Table of Contents

List of Tables 3

List of Figures 4

Report Guidance 5

GlobalData Clinical Trials Report Coverage 6

Clinical Trials by Region 7

Clinical Trials and Average Enrollment by Country 8

Top Five Countries Contributing to Clinical Trials in Asia-Pacific 11

Top Five Countries Contributing to Clinical Trials in Europe 12

Top Countries Contributing to Clinical Trials in North America 13

Top Five Countries Contributing to Clinical Trials in Middle East and Africa 14

Top Five Countries Contributing to Clinical Trials in Central and South America 15

Clinical Trials by G7 Countries: Proportion of Cognitive Disorders to Central Nervous System Clinical Trials 16

Clinical Trials by Phase in G7 Countries 18

Clinical Trials in G7 Countries by Trial Status 19

Clinical Trials by E7 Countries: Proportion of Cognitive Disorders to Central Nervous System Clinical Trials 21

Clinical Trials by Phase in E7 Countries 23

Clinical Trials in E7 Countries by Trial Status 24

Clinical Trials by Phase 26

In Progress Trials by Phase 27

Clinical Trials by Trial Status 28

Clinical Trials by End Point Status 30

Subjects Recruited Over a Period of Time 31

Clinical Trials by Sponsor Type 32

Prominent Sponsors 33

Top Companies Participating in Cognitive Disorders Therapeutics Clinical Trials 35

Prominent Drugs 37

Clinical Trial Profile Snapshots 38

Appendix 1912

Abbreviations 1912

Definitions 1912

Research Methodology 1913

Secondary Research 1913

About GlobalData 1914

Contact Us 1914

Source 1915


List Of Figure

List of Figures

Cognitive Disorders Therapeutics, Global, Clinical Trials by Region (%), 2019* 7

Cognitive Disorders Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2019* 8

Cognitive Disorders Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2019* 10

Cognitive Disorders Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2019* 11

Cognitive Disorders Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2019* 12

Cognitive Disorders Therapeutics Clinical Trials, North America, Top Countries (%), 2019* 13

Cognitive Disorders Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2019* 14

Cognitive Disorders Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2019* 15

Proportion of Cognitive Disorders to Central Nervous System Clinical Trials, G7 Countries (%), 2019* 16

Cognitive Disorders Therapeutics, G7 Countries, Clinical Trials by Phase, 2019* 18

Cognitive Disorders Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2019* 19

Proportion of Cognitive Disorders to Central Nervous System Clinical Trials, E7 Countries (%), 2019* 21

Cognitive Disorders Therapeutics, E7 Countries, Clinical Trials by Phase, 2019* 23

Cognitive Disorders Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2019* 24

Cognitive Disorders Therapeutics, Global, Clinical Trials by Phase (%), 2019* 26

Cognitive Disorders Therapeutics, Global, Clinical Trials In Progress by Phase, 2019* 27

Cognitive Disorders Therapeutics, Global, Clinical Trials by Trial Status, 2019* 28

Cognitive Disorders Therapeutics Clinical Trials, Global, by End Point Status, 2019* 30

Cognitive Disorders Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2014-2018 31

Cognitive Disorders Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2019* 32

Cognitive Disorders Therapeutics Clinical Trials, Global, Key Sponsors, 2019* 33

Cognitive Disorders Therapeutics Clinical Trials, Global, Top Companies by Phase, 2019* 35

Cognitive Disorders Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2019* 37

GlobalData Methodology 1913


List Of Table

List of Tables

Cognitive Disorders Therapeutics, Global, Clinical Trials by Region, 2019* 7

Cognitive Disorders Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2019* 9

Cognitive Disorders Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2019* 10

Cognitive Disorders Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2019* 11

Cognitive Disorders Therapeutics Clinical Trials, Europe, Top Five Countries, 2019* 12

Cognitive Disorders Therapeutics Clinical Trials, North America, Top Countries, 2019* 13

Cognitive Disorders Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2019* 14

Cognitive Disorders Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2019* 15

Proportion of Cognitive Disorders to Central Nervous System Clinical Trials, G7 Countries (%), 2019* 17

Cognitive Disorders Therapeutics, G7 Countries, Clinical Trials by Phase, 2019* 18

Cognitive Disorders Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2019* 20

Proportion of Cognitive Disorders to Central Nervous System Clinical Trials, E7 Countries (%), 2019* 22

Cognitive Disorders Therapeutics, E7 Countries, Clinical Trials by Phase, 2019* 23

Cognitive Disorders Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2019* 25

Cognitive Disorders Therapeutics, Global, Clinical Trials by Phase, 2019* 26

Cognitive Disorders Therapeutics, Global, Clinical Trials In Progress by Phase 2019* 27

Cognitive Disorders Therapeutics, Global, Clinical Trials by Trial Status, 2019* 29

Cognitive Disorders Therapeutics Clinical Trials, Global, by End Point Status, 2019* 30

Cognitive Disorders Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2014-2018 31

Cognitive Disorders Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2019* 32

Cognitive Disorders Therapeutics Clinical Trials, Global, Key Sponsors, 2019* 34

Cognitive Disorders Therapeutics Clinical Trials, Global, Top Companies by Phase, 2019* 36

Cognitive Disorders Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2019* 37

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Products and Companies


Companies

Pfizer Inc

Eisai Co Ltd

Novartis AG

Johnson & Johnson

Allergan Plc

Eli Lilly and Co

Takeda Pharmaceutical Co Ltd

The Lundbeck Foundation

C. H. Boehringer Sohn AG & Co KG

GlaxoSmithKline Plc

Company Profile

Company Profile Title

Cognitive Disorders Global Clinical Trials Review, H2, 2019

Summary

GlobalData's clinical trial report, Cognitive Disorders Global Clinical Trials Review, H2, 2019" provides an overview of Cognitive Disorders clinical trials scenario. This report provides top line data relating to the clinical trials on Cognitive Disorders. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database-Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides a snapshot of the global clinical trials landscape

- Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status

- The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company

- The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment

- The Report provides enrollment trends for the past five years

- Report provides latest news for the past three months

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to buy

- Assists in formulating key business strategies with regards to investment

- Helps in identifying prominent locations for conducting clinical trials which saves time and cost

- Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities

- Supports understanding of trials count and enrollment trends by country in global therapeutics market

- Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials

- Facilitates clinical trial assessment of the indication on a global, regional and country level

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

READ MORE

Scope

Table of Contents

List of Tables 3

List of Figures 4

Report Guidance 5

GlobalData Clinical Trials Report Coverage 6

Clinical Trials by Region 7

Clinical Trials and Average Enrollment by Country 8

Top Five Countries Contributing to Clinical Trials in Asia-Pacific 11

Top Five Countries Contributing to Clinical Trials in Europe 12

Top Countries Contributing to Clinical Trials in North America 13

Top Five Countries Contributing to Clinical Trials in Middle East and Africa 14

Top Five Countries Contributing to Clinical Trials in Central and South America 15

Clinical Trials by G7 Countries: Proportion of Cognitive Disorders to Central Nervous System Clinical Trials 16

Clinical Trials by Phase in G7 Countries 18

Clinical Trials in G7 Countries by Trial Status 19

Clinical Trials by E7 Countries: Proportion of Cognitive Disorders to Central Nervous System Clinical Trials 21

Clinical Trials by Phase in E7 Countries 23

Clinical Trials in E7 Countries by Trial Status 24

Clinical Trials by Phase 26

In Progress Trials by Phase 27

Clinical Trials by Trial Status 28

Clinical Trials by End Point Status 30

Subjects Recruited Over a Period of Time 31

Clinical Trials by Sponsor Type 32

Prominent Sponsors 33

Top Companies Participating in Cognitive Disorders Therapeutics Clinical Trials 35

Prominent Drugs 37

Clinical Trial Profile Snapshots 38

Appendix 1912

Abbreviations 1912

Definitions 1912

Research Methodology 1913

Secondary Research 1913

About GlobalData 1914

Contact Us 1914

Source 1915


List Of Figure

List of Figures

Cognitive Disorders Therapeutics, Global, Clinical Trials by Region (%), 2019* 7

Cognitive Disorders Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2019* 8

Cognitive Disorders Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2019* 10

Cognitive Disorders Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2019* 11

Cognitive Disorders Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2019* 12

Cognitive Disorders Therapeutics Clinical Trials, North America, Top Countries (%), 2019* 13

Cognitive Disorders Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2019* 14

Cognitive Disorders Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2019* 15

Proportion of Cognitive Disorders to Central Nervous System Clinical Trials, G7 Countries (%), 2019* 16

Cognitive Disorders Therapeutics, G7 Countries, Clinical Trials by Phase, 2019* 18

Cognitive Disorders Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2019* 19

Proportion of Cognitive Disorders to Central Nervous System Clinical Trials, E7 Countries (%), 2019* 21

Cognitive Disorders Therapeutics, E7 Countries, Clinical Trials by Phase, 2019* 23

Cognitive Disorders Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2019* 24

Cognitive Disorders Therapeutics, Global, Clinical Trials by Phase (%), 2019* 26

Cognitive Disorders Therapeutics, Global, Clinical Trials In Progress by Phase, 2019* 27

Cognitive Disorders Therapeutics, Global, Clinical Trials by Trial Status, 2019* 28

Cognitive Disorders Therapeutics Clinical Trials, Global, by End Point Status, 2019* 30

Cognitive Disorders Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2014-2018 31

Cognitive Disorders Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2019* 32

Cognitive Disorders Therapeutics Clinical Trials, Global, Key Sponsors, 2019* 33

Cognitive Disorders Therapeutics Clinical Trials, Global, Top Companies by Phase, 2019* 35

Cognitive Disorders Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2019* 37

GlobalData Methodology 1913


List Of Table

List of Tables

Cognitive Disorders Therapeutics, Global, Clinical Trials by Region, 2019* 7

Cognitive Disorders Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2019* 9

Cognitive Disorders Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2019* 10

Cognitive Disorders Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2019* 11

Cognitive Disorders Therapeutics Clinical Trials, Europe, Top Five Countries, 2019* 12

Cognitive Disorders Therapeutics Clinical Trials, North America, Top Countries, 2019* 13

Cognitive Disorders Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2019* 14

Cognitive Disorders Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2019* 15

Proportion of Cognitive Disorders to Central Nervous System Clinical Trials, G7 Countries (%), 2019* 17

Cognitive Disorders Therapeutics, G7 Countries, Clinical Trials by Phase, 2019* 18

Cognitive Disorders Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2019* 20

Proportion of Cognitive Disorders to Central Nervous System Clinical Trials, E7 Countries (%), 2019* 22

Cognitive Disorders Therapeutics, E7 Countries, Clinical Trials by Phase, 2019* 23

Cognitive Disorders Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2019* 25

Cognitive Disorders Therapeutics, Global, Clinical Trials by Phase, 2019* 26

Cognitive Disorders Therapeutics, Global, Clinical Trials In Progress by Phase 2019* 27

Cognitive Disorders Therapeutics, Global, Clinical Trials by Trial Status, 2019* 29

Cognitive Disorders Therapeutics Clinical Trials, Global, by End Point Status, 2019* 30

Cognitive Disorders Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2014-2018 31

Cognitive Disorders Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2019* 32

Cognitive Disorders Therapeutics Clinical Trials, Global, Key Sponsors, 2019* 34

Cognitive Disorders Therapeutics Clinical Trials, Global, Top Companies by Phase, 2019* 36

Cognitive Disorders Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2019* 37

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS


Companies

Pfizer Inc

Eisai Co Ltd

Novartis AG

Johnson & Johnson

Allergan Plc

Eli Lilly and Co

Takeda Pharmaceutical Co Ltd

The Lundbeck Foundation

C. H. Boehringer Sohn AG & Co KG

GlaxoSmithKline Plc